| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34922020_HAS_TOPIC_C0003451> <https://research.tib.eu/covid-19/entity/34922020_HAS_TOPIC_C0013185> <https://research.tib.eu/covid-19/entity/34922020_HAS_TOPIC_C0022886> <https://research.tib.eu/covid-19/entity/34922020_HAS_TOPIC_C0035168> <https://research.tib.eu/covid-19/entity/34922020_HAS_TOPIC_C0035170> <https://research.tib.eu/covid-19/entity/34922020_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34922020_HAS_TOPIC_C0242481> <https://research.tib.eu/covid-19/entity/34922020_HAS_TOPIC_C0376368> <https://research.tib.eu/covid-19/entity/34922020_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34922020_HAS_TOPIC_C5387588> <https://research.tib.eu/covid-19/entity/34922020_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/34922020_HAS_TOPIC_C5398043>
?:authorAffiliation	[\'Worldwide Research, Development and Medical, Pfizer Inc, United States.\', \'Worldwide Research, Development and Medical, Pfizer Inc, United States. Electronic address: mikael.dolsten@pfizer.com.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Dolsten_Mikael> <https://research.tib.eu/covid-19/entity/Fernando_Kathy> <https://research.tib.eu/covid-19/entity/Jansen_Kathrin> <https://research.tib.eu/covid-19/entity/Menon_Sandeep> <https://research.tib.eu/covid-19/entity/Naik_Prakash> <https://research.tib.eu/covid-19/entity/Nucci_Gianluca> <https://research.tib.eu/covid-19/entity/Roberts_John> <https://research.tib.eu/covid-19/entity/Wu_Shuang_Sarah>
?:doi	S1359-6446(21)00544-410.1016/j.drudis.2021.12.010
?:doi	<https://research.tib.eu/covid-19/entity/S1359-6446%2821%2900544-410.1016/j.drudis.2021.12.010>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Drug discovery today
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34922020>
?:pmid	<https://research.tib.eu/covid-19/entity/34922020>
?:pmid	34922020
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	2.008
?:rankingScore_hIndex	150
?:title	Achieving end-to-end success in the clinic: Pfizer\'s learnings on R&D productivity.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2022

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/34922020>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/34922020>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all